BTC Health (ASX:BTC) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is BTC Health Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ASX:BTC vs VRTX, REGN, RVMD: Short Percentage of Float Comparison

For the Biotechnology subindustry, BTC Health's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BTC Health Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BTC Health's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where BTC Health's Short Percentage of Float falls into.


BTC Health Business Description

Address 10 Oxley Road, Level 1, Hawthorn, Melbourne, VIC, AUS, 3122
BTC Health Ltd is a pooled development fund focused on seeking new investment opportunities in entities operating in the biotechnology and life sciences sectors. Its sole operating segment involves making and managing healthcare ventures. The company's products include Elasto-Q, Rythmic Infusion Pumps, Tiva, Infusion and Nerve Catheter Kits, Biopsy Needles, Radiological Markers, Rebellion Bone Removal System, Bonopty Coaxial Bone Biopsy, ECLS (Extracorporeal Life Support) Oxygenators, Pears, Valves, NEOLA, and LPS Adsorber. Geographically, it operates in Australia.